2006
DOI: 10.1136/jme.2005.013599
|View full text |Cite
|
Sign up to set email alerts
|

The promise and predicament of cosmetic neurology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
59
0
6

Year Published

2008
2008
2018
2018

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 96 publications
(66 citation statements)
references
References 33 publications
1
59
0
6
Order By: Relevance
“…Some employees might decline to use them, either because of concern about their safety or a more general concern about deleterious effects of longer hours and increased productivity on their health. If the drugs were effective, then those who declined to use them could be at a competitive disadvantage compared with their colleagues who used them [5,12]. This could jeopardize their jobs.…”
Section: Social Issuesmentioning
confidence: 99%
“…Some employees might decline to use them, either because of concern about their safety or a more general concern about deleterious effects of longer hours and increased productivity on their health. If the drugs were effective, then those who declined to use them could be at a competitive disadvantage compared with their colleagues who used them [5,12]. This could jeopardize their jobs.…”
Section: Social Issuesmentioning
confidence: 99%
“…The development of new classes of drugs that do not seek to improve a disease, but are targeted directly to the healthy subject such as the AMPAkines and modulators of protein binding to the response element of CAMP (CREB) 25 ,is particularly intriguing. These drugs promote a cascade of intracellular events that lead to neuronal structural changes related to the acquisition of long-term memories.…”
Section: "If X Treatment Can Relieve a Significant Deficit In Psycholmentioning
confidence: 99%
“…For example, serotonin reuptake inhibitors (SIRS) promote affiliative behavior in healthy situations; dopamine agonists can improve the acquisition of motor skills and are associated with an increased neural plasticity; cholinesterase inhibitors can improve normal performance under certain circumstances. New non-addictive stimulants, such as Atomoxetine, seem to improve levels of excitation in normal subjects 25 .…”
Section: "If X Treatment Can Relieve a Significant Deficit In Psycholmentioning
confidence: 99%
“…The debate over "cosmetic neurology" [1,2] has, until now, focused on the patient as consumer but not on the special case of the physician as patient.The availability of pharmacologic therapies for the treatment of sleep, attention, memory, mood, and endurance disorders introduces the option (subject to legal and ethical constraints) of using these agents to enhance cognitive function in healthy individuals. The anticipated availability within the next few years of more potent "smart pills" aimed at the molecular base of specific brain functions, and the more distant yet conceivable prospect of direct microelectronic brain interfacing to restore lost-or enhance existing-natural functions, raise many interesting and challenging ethical questions [3].…”
mentioning
confidence: 99%
“…The debate over "cosmetic neurology" [1,2] has, until now, focused on the patient as consumer but not on the special case of the physician as patient.…”
mentioning
confidence: 99%